Table 1.
Baseline characteristics
| Amlodipinea (n = 103) | Atorvastatina (n = 104) | Amlodipine + atorvastatina (n = 104) | |
|---|---|---|---|
| Age, mean (SD) (years) | 61.4 (9.0) | 62.5 (8.6) | 62.8 (8.7) |
| Weight, mean (SD) (kg) | 78.9 (10.9) | 81.0 (12.9) | 79.3 (11.9) |
| Diabetes, n (%) | 29 (28.2) | 23 (22.1) | 26 (25.0) |
| Hypertension, n (%) | 72 (69.9) | 83 (79.8) | 72 (69.2) |
| Hyperlipidaemia, n (%) | 75 (72.8) | 82 (78.8) | 84 (80.8) |
| Previous MI, n (%) | 53 (51.5) | 59 (56.7) | 62 (59.6) |
| TC, mean (SD) (mmol/L) | 6.13 (1.0) | 6.16 (1.0) | 5.93 (1.1) |
| LDL-C, mean (SD) (mmol/L) | 3.9 (1.2) | 4.0 (1.1) | 3.9 (0.9) |
| HDL-C, mean (SD) (mmol/L) | 1.2 (0.4) | 1.3 (0.3) | 1.3 (0.3) |
| TG, mean (SD) (mmol/L) | 2.1 (1.2) | 1.8 (0.8) | 1.9 (0.9) |
| SBP, mean (SD) (mmHg) | 131.7 (12.2) | 135.0 (13.0) | 131.9 (11.8) |
| DBP, mean (SD) (mmHg) | 80.0 (6.3) | 81.4 (6.8) | 80.4 (6.4) |
DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; SBP, systolic blood pressure; SD, standard deviation; TC, total cholesterol; TG, triglycerides.
aThere was no statistical difference between treatment groups for the baseline characteristics with the exception of TG (P < 0.05).